Cargando…
Incidence rate of modifying or discontinuing first combined antiretroviral therapy regimen due to toxicity during the first year of treatment stratified by age
Toxicity is the most frequently reported reason for modifying or discontinuing the first combined antiretroviral therapy regimens, and it can cause significant morbidity, poor quality of life and also can be an important barrier to adherence, ultimately resulting in treatment failure and viral resis...
Autores principales: | Torres, Thiago Silva, Cardoso, Sandra Wagner, Velasque, Luciane S., Veloso, Valdilea G., Grinsztejn, Beatriz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425238/ https://www.ncbi.nlm.nih.gov/pubmed/24029435 http://dx.doi.org/10.1016/j.bjid.2013.04.005 |
Ejemplares similares
-
Effectiveness of first-line antiretroviral therapy in the IPEC cohort, Rio de Janeiro, Brazil
por: Cardoso, Sandra W, et al.
Publicado: (2014) -
Towards an ideal antiretroviral regimen for the global HIV epidemic
por: Grinsztejn, Beatriz, et al.
Publicado: (2017) -
Outcomes of second-line combination antiretroviral therapy for HIV-infected patients: a cohort study from Rio de Janeiro, Brazil
por: Cardoso, Sandra W, et al.
Publicado: (2014) -
Long-Term CD4+ Cell Count in Response to Combination Antiretroviral Therapy
por: Luz, Paula M., et al.
Publicado: (2014) -
Absence of Effect of Menopause Status at Initiation of First-Line Antiretroviral Therapy on Immunologic or Virologic Responses: A Cohort Study from Rio de Janeiro, Brazil
por: Calvet, Guilherme Amaral, et al.
Publicado: (2014)